Filing Flows

Filing Flows › Ideaya Biosciences (IDYA) › Next earnings date

Ideaya Biosciences (IDYA) earnings: missed the estimate

Ideaya Biosciences (IDYA) reported on Nov 3, 2026 and missed the EPS estimate: −$1.22 against −$1.16 (-4.9%). Revenue was $10.2M for Q3 2026, -95% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result−4.9% vs estimate
Beat rate40%

The last report

Ideaya Biosciences reported revenue of $10.2M for the third quarter 2026 (-95% Y/Y), net loss $126M. How it makes money → · Every quarter →

Ideaya Biosciences: EPS against the estimate, last 5 reportsIdeaya Biosciences: EPS against the estimate, last 5 reportsEstimateReported−$0.55$1.33Nov 25−$0.95−$0.94Feb 26−$0.98−$1.11May 26−$1.05−$1.22Aug 26−$1.16−$1.22Nov 26
Latest (Nov 26): Estimate −$1.16, Reported −$1.22.
IDYA: the stock's move on each reportIDYA: the stock's move on each reportAug 4, 2026+1.8%May 5, 2026-0.6%Feb 17, 2026+2.1%Nov 4, 2025-5.4%

Ideaya Biosciences' latest quarter

Ideaya Biosciences, Q3 2026: revenue $10.2M (-95% year over year), net loss $126M, operating cash flow −$93.5M. The chart follows the revenue to costs, profit and cash.

Questions

Did Ideaya Biosciences beat earnings?

Ideaya Biosciences (IDYA) reported on Nov 3, 2026 and missed the EPS estimate: −$1.22 against −$1.16 (-4.9%).

When does IDYA report earnings?

The next date is not set yet.

Does Ideaya Biosciences usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.